Search by Drug Name or NDC
NDC 65219-0479-10 LACTATED RINGERS 20; 30; 600; 310 mg/100mL; mg/100mL; mg/100mL; mg/100mL Details
LACTATED RINGERS 20; 30; 600; 310 mg/100mL; mg/100mL; mg/100mL; mg/100mL
LACTATED RINGERS is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Fresenius Kabi USA, LLC. The primary component is CALCIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE.
Product Information
NDC | 65219-0479 |
---|---|
Product ID | 65219-479_1050d171-31f0-431d-94ec-059c36f742e3 |
Associated GPIs | |
GCN Sequence Number | 001187 |
GCN Sequence Number Description | Ringer's solution,lactated IV SOLN INTRAVEN |
HIC3 | C1W |
HIC3 Description | ELECTROLYTE MAINTENANCE |
GCN | 02840 |
HICL Sequence Number | 000525 |
HICL Sequence Number Description | RINGER'S SOLUTION,LACTATED |
Brand/Generic | Generic |
Proprietary Name | LACTATED RINGERS |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | SODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | INJECTION, SOLUTION |
Route | INTRAVENOUS |
Active Ingredient Strength | 20; 30; 600; 310 |
Active Ingredient Units | mg/100mL; mg/100mL; mg/100mL; mg/100mL |
Substance Name | CALCIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE |
Labeler Name | Fresenius Kabi USA, LLC |
Pharmaceutical Class | Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Larg |
DEA Schedule | n/a |
Marketing Category | ANDA |
Application Number | ANDA209338 |
Listing Certified Through | 2024-12-31 |
Package
NDC 65219-0479-10 (65219047910)
NDC Package Code | 65219-479-10 |
---|---|
Billing NDC | 65219047910 |
Package | 10 BAG in 1 CASE (65219-479-10) / 1000 mL in 1 BAG (65219-479-05) |
Marketing Start Date | 2019-01-28 |
NDC Exclude Flag | N |
Pricing Information | N/A |